BOLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Bolt Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.04+0.04 (+1.00%)
Close on Oct 19, 2026
- Market cap
- $6.83M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Bolt Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 1, 2026 | Oct 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 27, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Current report | 8-K | May 27, 2025 | May 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 16, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2025 | Apr 15, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 2, 2025 | Jan 3, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2024 | Sep 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2024 | Jul 3, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 14, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 14, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2024 | Apr 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 21, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 9, 2023 | Nov 9, 2023 | SEC EDGAR |